Franklin Biotechnology Discovery Fund's Q1 2025 report covers market trends, key holdings, risks, and outlook—essential ...

A nonprofit incubator said it will take over a 33,000-square-foot building in Richmond, which also possesses manufacturing ...

Biotechnology advances the plastics industry by employing living cells and enzymes to create eco-friendly solutions and ...

Vir Biotechnology, Inc.’s VIR share price has dipped by 5.45%, which has investors questioning if this is right time to buy.

The Eighth Judicial Circuit Solicitor’s Office said an Abbeville County man was sentenced to prison after changing his plea ...

More than 300 attendees came together to celebrate the academic success of graduating students and to honor faculty and staff ...

Anbio Biotechnology’s NNNN share price has surged by 5.23%, which has investors questioning if this is right time to sell.

Vir Biotechnology (VIR) delivered earnings and revenue surprises of -6.02% and 84.51%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

Ph.D., MBA, Chief Executive Officer, Vir Biotechnology. "We successfully dosed the first patient in our ECLIPSE Phase 3 registrational program for hepatitis delta, a devastating disease with no ...

These preclinical candidates integrate the PRO-XTEN™ masking technology with novel TCEs discovered and engineered using Vir Biotechnology’s antibody discovery platform and the Company’s ...

Scientists at Oak Ridge National Laboratory and the University of Colorado Boulder used a gene-silencing tool and a large ...